ENGN short interest
enGene Holdings Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 1,394,394 |
|---|---|
| Change vs prior report | 194,718 (+16.2%) |
| Change over six months | +21.7% |
| Days to cover | 1.81 (sector: 3.78) |
| Average daily volume | 770,258 |
| Rank in Healthcare | #718 of 922 by days to cover |
ENGN short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 1,394,394 | +16.2% | 1.81 | 770,258 |
| 2026-09-15 | 1,199,676 | -2.1% | 1.71 | 700,551 |
| 2026-08-31 | 1,225,010 | -18.1% | 1.78 | 688,120 |
| 2026-08-14 | 1,495,277 | -13.7% | 2.20 | 680,801 |
| 2026-07-31 | 1,733,296 | +5.7% | 2.55 | 680,561 |
| 2026-07-15 | 1,640,215 | +43.7% | 1.31 | 1,255,969 |
| 2026-06-30 | 1,141,694 | -17.9% | 1.02 | 1,116,776 |
| 2026-06-15 | 1,390,080 | -14.3% | 1.62 | 859,253 |
| 2026-05-29 | 1,622,269 | +11.5% | 1.11 | 1,466,173 |
| 2026-05-15 | 1,455,269 | -27.4% | 1.00 | 5,752,614 |
| 2026-04-30 | 2,003,419 | +50.5% | 3.80 | 527,718 |
| 2026-04-15 | 1,330,981 | +16.1% | 6.67 | 199,435 |
| 2026-03-31 | 1,145,907 | +24.2% | 4.10 | 279,661 |
| 2026-03-13 | 922,661 | -25.3% | 1.02 | 906,038 |
| 2026-02-27 | 1,235,753 | -17.7% | 10.36 | 119,320 |
| 2026-02-13 | 1,501,696 | -31.5% | 4.59 | 327,514 |
| 2026-01-30 | 2,192,033 | +52.2% | 3.71 | 590,195 |
| 2026-01-15 | 1,440,058 | -3.8% | 5.46 | 263,543 |
| 2025-12-31 | 1,497,488 | +32.4% | 5.58 | 268,316 |
| 2025-12-15 | 1,130,950 | -0.7% | 4.24 | 266,782 |
| 2025-11-28 | 1,139,282 | -4.1% | 1.59 | 714,285 |
| 2025-11-14 | 1,187,663 | +3963.2% | 1.00 | 5,525,135 |
| 2025-10-31 | 29,230 | -49.2% | 1.00 | 237,448 |
| 2025-10-15 | 57,496 | +53.9% | 1.00 | 468,655 |
| 2025-09-30 | 37,357 | -17.2% | 1.00 | 314,177 |
import finzdata as yf
yf.Ticker("ENGN").short_interest # every report since 2017
yf.Client().short_interest(["ENGN"], start="2018-01-01")Healthcare short interest · ENGN price history · Who owns ENGN · All short interest